FDA sends warning letter over alleged violations at leading device reprocessor Alliance Medical
This article was originally published in Clinica
In the midst of discussions over the regulation of third-party medical device reprocessors, the US FDA has side-stepped its critics by issuing a highly publicised warning letter to industry leader Alliance Medical. The warning letter claimed that agency inspectors uncovered serious problems at the Phoenix, Arizona-based company's decontamination facility in Florida.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”